Public Safety Advocacy Group Asks For Warning on Tigecycline

Written By: Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP

Nov 22, 2011

The public safety advocacy group Public Citizen has called upon the FDA to ensure that the antibiotic tigecycline is marked with a black box warning -- due to the fact that there is a higher mortality rate with that drug than with other popular antibiotics. Public Citizen's Health Research Group deputy director reports that the mortality rate is 30% higher with tigecycline. In conjunction with that frightening statistic, it was found that the antibiotic also has higher rates of failure to cure serious infections in comparative studies. Currently, the drug's label does little to inform the consumer about its side effects.

Categories:

Don't Settle

for an Average Attorney

- Name:
  
  Please enter your name.
- Phone
  
  This isn't a valid phone number.
- Email:
  
  Please enter your email address.
  
  This isn't a valid email address.
- Are you a new client?
  
  Please make a selection.
- Message
  
  Please enter a message.

Get RGRP On Your Side